| Literature DB >> 22957028 |
Gerben ter Riet1, Daniel A Korevaar, Marlies Leenaars, Peter J Sterk, Cornelis J F Van Noorden, Lex M Bouter, René Lutter, Ronald P Oude Elferink, Lotty Hooft.
Abstract
CONTEXT: Publication bias jeopardizes evidence-based medicine, mainly through biased literature syntheses. Publication bias may also affect laboratory animal research, but evidence is scarce.Entities:
Mesh:
Year: 2012 PMID: 22957028 PMCID: PMC3434185 DOI: 10.1371/journal.pone.0043404
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary responses to a survey among Dutch experimental animal researchers.
| Question | Scale | N | Median (p25–p75) |
| 6. Overall, what % of ethics-approved experiments performed in experimental animalresearch is published? | 0–100% | 454 | 50 (32–70) |
| 7. Overall, what % of animal experiments you have been involved in have been published on? | 0–100% | 215 | 80 (60–90) |
| 8. Do you consider publication bias a problem for experimental animal research? | 1–10 (not at all - extremely) | 448 | 7 (5–8) |
| 9. What are important causes of non-publication in experimental animal research? | 1–5 (totally unimportant - very important) | 444 | |
| 1. Lack of statistically significant differences (“negative” findings) | 4 (4–5) | ||
| 2. Instrumentation/technical problems | 4 (3–4) | ||
| 3. Lack of time to write manuscripts | 2 (2–3) | ||
| 4. Loss of interest | 2.5 (2–3) | ||
| 5. Many studies are seen as pilot studies only | 3 (3–4) | ||
| 10. Who are responsible for non-publication in experimental animal research? | 1–5 (least important - most important) | 440 | |
| 1. Senior researchers (supervisors) | 4 (3–5) | ||
| 2. Junior researchers (research fellow/PhD) | 3 (2–4) | ||
| 3. Editors | 4 (3–4) | ||
| 4. Reviewers/Referees | 4 (3–5) | ||
| 5. Funders | 2 (1–4) | ||
| 11. Publication bias is important for experimental animal research with respect to: | 1–10 (totally unimportant – extremely important) | 434 | |
| 1. Duplication of research efforts | 8 (7–9) | ||
| 2. Bias in literature reviews or meta-analyses | 8 (7–9) | ||
| 3. Initiation of phase-1 clinical trials in humans | 7 (6–8) | ||
| 12. Would you use initiatives to make the publishing of negative results or commentson why an experiment could not be completed much easier, for example an (anonymous)online database or (online) journals of negative result? | 1–3 (1 = never, 2 = sometimes, 3 = often/always) | 432 | 2 (2–3) |
| 14. Mandatory anonymous publication of | 1–5 (extreme increase - extreme decrease) | 426 | |
| 1. Duplication of research efforts | 4 (3–4) | ||
| 2. Validity of literature reviews | 2 (2–3) | ||
| 3. Certainty that competing investigators do not catch up | 3 (3–4) | ||
| 4. Bureaucracy | 2 (1–3) | ||
| 5. Overall scientific progress | 2 (2–3) | ||
|
|
|
|
|
| 15. Mandatory anonymous publication of a brief structured form in a publically availabledatabase, that gave | 1–5 (extreme increase - extreme decrease) | 423 | |
| 1. Duplication of research efforts | 4 (3–4) | ||
| 2. Validity of literature reviews | 2 (2–3) | ||
| 3. Certainty that competing investigators do not catch up | 3 (3–4) | ||
| 4. Bureaucracy | 2 (2–3) | ||
| 5. Overall scientific progress | 2 (2–3) |
Questions are numbered according to the survey in which questions 1 to 5 enquired after respondents’ background characteristics (Appendix S2).
Between 17 March and 30 July 2011, 474 laboratory animal researchers returned the survey. Fifty-one respondents did not fill in the survey completely. Of these, we excluded 20 because of absence of (at least) their background data. The variation in the total number of 454 respondents across table 1 is caused by the other 31 respondents.
The group that (co-)authored 0–5 studies was excluded from this row because very junior investigators very often had either zero or 100 percent of their papers publish.